Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1989-07-11
1990-11-27
Rollins, John W.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 24, C07H 1700
Patent
active
049736779
ABSTRACT:
There are disclosed novel 2',3'-dideoxy-2'-fluoronucleosides and 2'-3'-dideoxy-2',3'-didehydro-2'-fluoronucleosides and processes for their preparation. The compounds so produced exhibit therapeutically useful antiviral and, more particularly, anti-HIV effects.
REFERENCES:
Kinney-Thomas et al., Biochemical Pharmacology, vol. 36 (1987), pp. 311-316.
DDI Promising in Clinical Trails. Scrip. Jun. 21, 1989, p. 1422.
Mitsuya et al., Proc. Natl. Acad. Sci. U.S.A. 83 (1986), pp. 1911-1915.
Chemical Engineering News, Nov. 23, 1987, pp. 44, 45 & 48.
Baba et al. Biochem & Biophys. Res. Comm. 142, No. 1, 1987, pp. 128-134.
Yarchoan et al., The Lancet. Jan. 16, 1988, pp. 76-80.
Mansuri Muzammil M.
Martin John C.
Sterzycki Roman Z.
Algieri Aldo A.
Bristol-Myers Company
Rollins John W.
LandOfFree
2',3'-dideoxy-2',3'-didehydro-2'-fluoroarabino-nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2',3'-dideoxy-2',3'-didehydro-2'-fluoroarabino-nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2',3'-dideoxy-2',3'-didehydro-2'-fluoroarabino-nucleosides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1032471